Evidence map›Paper›PMID 29248292›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2018

Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.

Christopher S Digesu, Krista J Hachey, Denis M Gilmore, Onkar V Khullar, Hisashi Tsukada, Brian Whang, Lucian R Chirieac, Robert F Padera, Michael T Jaklitsch, Yolonda L Colson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Sentinel lymph node biopsy for lung cancer.General thoracic and cardiovascular surgery · 2020
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Christopher S DigesuDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, Mass.
Krista J HacheyDepartment of Surgery, Boston Medical Center, Boston, Mass.
Denis M GilmoreDepartment of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Onkar V KhullarDivision of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Ga.
Hisashi TsukadaDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, Mass.
Brian WhangDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, Mass.
Lucian R ChirieacDepartment of Pathology, Brigham and Women's Hospital, Boston, Mass.
Robert F PaderaDepartment of Pathology, Brigham and Women's Hospital, Boston, Mass.
Michael T JaklitschDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, Mass.
Yolonda L ColsonDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, Mass. Electronic address: ycolson@partners.org.
Brigham and Women's Hospital · USBoston Medical Center · USEmory University · USVanderbilt University Medical Center · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
ADVANCED TRAINING IN SURGICAL ONCOLOGYT32CA009535 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BUENO, RAPHAEL · 1985 to 2015
$3.5M
NIR Imaging of Sentinel Nodes in Lung Cancer: Finding MicrometastasesR01CA131044 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI COLSON, YOLONDA L · 2008 to 2011
$1.5M
NCATS NIH HHS UL1 TR001102NCI NIH HHS R01 CA131044NCI NIH HHS T32 CA009535
6 · The paper itself

Abstract

objectiveTo report the first analysis of long-term outcomes using near-infrared (NIR) image-guided sentinel lymph node (SLN) mapping in non-small cell lung cancer (NSCLC).

methodsRetrospective analysis of patients with NSCLC enrolled in 2 prospective phase 1 NIR-guided SLN mapping trials, including an indocyanine green (ICG) dose-escalation trial, was performed. All patients underwent NIR imaging for SLN identification followed by multistation mediastinal lymph node sampling (MLNS) and pathologic assessment. Disease-free (DFS) and overall survival (OS) were compared between patients with NIR

resultsSLN detection, recurrence, DFS, and OS were assessed in 42 patients with NSCLC who underwent intraoperative peritumoral ICG injection, NIR imaging, and MLNS. NIR

conclusionsPatients with pN0 SLNs showed favorable disease-free and overall survival. This preliminary review of NIR SLN mapping in NSCLC suggests that pN0 SLNs may better represent true N0 status. A larger clinical trial is planned to validate these findings.

Indexed as

Spectroscopy, Near-InfraredAgedCarcinoma, Non-Small-Cell LungClinical Trials, Phase I as TopicDisease-Free SurvivalFemaleFluorescent DyesHumansIndocyanine GreenLung NeoplasmsLymphatic MetastasisLymph Node ExcisionMaleMiddle AgedNeoplasm StagingPneumonectomyFluorescent DyesIndocyanine Greenlung cancernear-infraredoutcomessentinel lymph node

Identifiers

PMID29248292
PMCPMC5816699
OpenAlexW2768622955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.